The notes are set to carry an interest of 4.65% annum payable semi-annually in arrear, which will mature five years from the date of issue.
Thomson Medical Group has launched and priced $160 million of notes due 2029, according to an Oct 21 bourse filing.
The notes are issued under the group’s $1 billion multi-currency debt issuance programme, which was established on June 28, 2019.
